Evidence for specific cognitive deficits in preclinical Huntington's disease

Brain

Volumn 121, Issue 7, 1998, Pages 1329-1341

  Lawrence, Andrew D ^a,b,g   Hodges, John R ^b,c   Rosser, Anne E ^b,d   Kershaw, Ann ^e   Ffrench Constant, Charles ^d,e   Rubinsztein, David C ^e   Robbins, Trevor W ^a,d   Sahakian, Barbara J ^b,f  

^a UK   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c MRC COGNITION AND BRAIN SCIENCES UNIT   (United Kingdom)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^e ADDENBROOKE S HOSPITAL   (United Kingdom)

^f UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^g HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Attention; Executive function; Huntington's disease; Memory; Preclinical

Indexed keywords

ARTICLE; COGNITIVE DEFECT; GENETIC RISK; HETEROZYGOTE; HUMAN; HUNTINGTON CHOREA; INTELLIGENCE QUOTIENT; MAJOR CLINICAL STUDY; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL;

ADULT; ATTENTION; COGNITION DISORDERS; DISCRIMINATION (PSYCHOLOGY); FEMALE; HUMANS; HUNTINGTON DISEASE; LEARNING; MALE; MEMORY; MIDDLE AGED; MOTOR ACTIVITY; PATTERN RECOGNITION, VISUAL; PSYCHOMETRICS; REACTION TIME; SPACE PERCEPTION; VISUAL PERCEPTION;

EID: 0031814175     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/121.7.1329     Document Type: Article

References (91)

1. Albin RL, Reiner A, Anderson KD, Dure LS 4th, Handelin B, Balfour R, et al. Preferential loss of striato-external pallidal projection neurons in presymptomatic Huntington's disease. Ann Neurol 1992; 31: 425-30.
2. Alexander GE, Delong MR, Strick PL. Parallel organisation of functionally segregated circuits linking basal ganglia and cortex. [Review]. Annu Rev Neurosci 1986; 9: 357-81.
3. Andrew SE, Goldberg YP, Kremer B, Telenius, Theilmann J, et al. The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease [see comments]. Nat Genet 1993; 4: 398-403. Comment in: Nat Genet 1993; 4: 329-30.
4. Andrew SE, Goldberg YP, Kremer B, Telenius, Theilmann J, et al. The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease [see comments]. Nat Genet 1993; 4: 398-403. Comment in: Nat Genet 1993; 4: 329-30.
5. Antonini A, Leenders KL, Spiegel R, Meier D, Vontobel, Weigell-Weber M, et al. Striatal glucose metabolism and dopamine D2 receptor binding in asymptomatic gene carriers and patients with Huntington's disease. Brain 1996; 119: 2085-95.
6. Arikuni T, Kubota K. The organization of prefrontocaudate projections and their laminar origin in the macaque monkey: a retrograde study using HRP-gel. J Comp Neurol 1986; 244: 492-510.
7. Augood SJ, Faull RL, Love DR, Emson PC. Reduction in enkephalin and substance P messenger RNA in the striatum of early grade Huntington's disease: a detailed cellular in situ hybridization study. Neuroscience 1996; 72: 1023-36.
8. Aylward EH, Codori AM, Barta PE, Pearlson GD, Harris GJ, Brandt J. Basal ganglia volume and proximity to onset in presymptomatic Huntington disease. Arch Neurol 1996; 53: 1293-6.
9. Barr A, Brandt J. Word-list generation deficits in dementia. J Clin Exp Neuropsychol 1996; 18: 810-22.
10. Benton AL, Hamsher K de S. Multilingual aphasia examination. Iowa City (IA): University of Iowa; 1976.
11. Bhide PG, Day M, Sapp E, Schwarz C, Sheth A, Kim J, et al. Expression of normal and mutant huntingtin in the developing brain. J Neurosci 1996; 16: 5523-35.
12. Blackmore L, Simpson SA, Crawford JR. Cognitive performance in UK sample of presymptomatic people carrying the gene for Huntington's disease. J Med Genet 1995; 32: 358-62.
13. Brandt J, Butters N. Neuropsychological characteristics of Huntington's disease. In: Grant I, Adams KM, editors. Neuropsychological assessment of neuropsychiatric disorders. 2nd ed. New York: Oxford University Press; 1996. p. 312-41.
14. Buchwald NA, Hull CD, Levine MS, Villablanca J. The basal ganglia and the regulation of response and cognitive sets. In: Brazier MAB, editor. Growth and development of the brain. New York: Raven Press; 1975. p. 171-189.
15. Buerger AA, Gross CG, Rocha-Miranda CE. Effects of ventral putamen lesions on discrimination learning by monkeys. J Comp Physiol Psychol 1974; 86: 440-6.
16. Butters N. The clinical aspects of memory disorders: contributions from experimental studies of amnesia and dementia. J Clin Neuropsychol 1984; 6: 17-36.
17. Campodonico JR, Codori AM, Brandt J. Neuropsychological stability over two years in asymptomatic carriers of the Huntington's disease mutation. J Neurol Neurosurg Psychiatry 1996; 61: 621-4.
18. Chan AS, Butters N, Salmon DP, Johnson SA, Paulsen JS, Swenson MR. Comparison of the semantic networks in patients with dementia and amnesia. Neuropsychology 1995; 9: 177-86.
19. Chen EY, Shapleske J, Luque R, McKenna PJ, Hodges JR, Calloway SP, et al. The Cambridge Neurological Inventory: a clinical instrument for assessment of soft neurological signs in psychiatric patients. Psychiatry Res 1995; 56: 183-204.
20. de Boo GM, Tibben A, Lanser JB, Jennekens-Schinkel A, Hermans J, Maat-Kievit A, et al. Early cognitive and motor symptoms in identified carriers of the gene for Huntington disease. Arch Neurol 1997; 54: 1353-7.
21. Diamond R, White RF, Myers RH, Mastromauro C, Koroshetz WJ, Butters N, et al. Evidence of presymptomatic cognitive decline in Huntington's disease. J Clin Exp Neuropsychol 1992; 14: 961-75.
22. Dias R, Robbins TW, Roberts AC. Dissociation in prefrontal cortex of affective and attentional shifts. Nature 1996; 380: 69-72.
23. Divac I, Rosvold HE, Szwarcbart MK. Behavioral effects of selective ablation of the caudate nucleus. J Comp Physiol Psychol 1967; 63: 184-90.
24. Downes JJ, Roberts AC, Sahakian BJ, Evenden JL, Morris RG, Robbins TW. Impaired extra-dimensional shift performance in medicated and unmedicated Parkinson's disease: evidence for a specific attentional dysfunction. Neuropsychologia 1989; 27: 1329-43.
25. Downes JJ, Sharp HM, Costall BM, Sagar HJ, Howe J. Alternating fluency in Parkinson's disease. Brain 1993; 116: 887-902.
26. Dunnett SB. Functional repair of striatal systems by neural transplants: evidence for circuit reconstruction. [Review]. Behav Brain Res 1995; 66: 133-42.
27. ffrench-Constant C. The Cambridge Huntington's disease clinic. Window on Addenbrooke's 1996; 1(24): 1-2.
28. Folstein SE. Huntington's disease: a disorder of families. Baltimore (MD): Johns Hopkins University Press; 1989.
29. Folstein MF, Folstein SE, McHugh PR. 'Minimental state'. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-98.
30. Foroud T, Siemers E, Kleindorfer D, Bill DJ, Hode ME, Norton JA, et al. Cognitive scores in carriers of Huntington's disease gene compared to noncarriers. Ann Neurol 1995; 37; 657-64.
31. Furtado S, Suchowersky O, Rewcastle B, Graham L, Klimek ML, Garber A. Relationship between trinucleotide repeats and neuropathological changes in Huntington's disease. Ann Neurol 1996; 39: 132-6.
32. Georgiou N, Bradshaw JL, Phillips JG, Bradshaw JA, Chiu E. The Simon effect and attention deficits in Gilles de la Tourette's syndrome and Huntington's disease. Brain 1995; 118: 1305-18.
33. Georgiou N, Bradshaw JL, Phillips JG, Chiu E. The effect of Huntington's disease and Gilles de la Tourette's syndrome on the ability to hold and shift attention. Neuropsychologia 1996; 34: 843-51.
34. Giordani B, Berent S, Boivin MJ, Penney JB, Lehtinen S, Markel DS, et al. Longitudinal neuropsychological and genetic linkage analysis of persons at risk for Huntington's disease. Arch Neurol 1995; 52: 59-64.
35. Goel V, Grafman J. Are the frontal lobes implicated in 'planning' functions? Interpreting data from the Tower of Hanoi. Neuropsychologia 1995; 33: 623-42.
36. Gomez-Tortosa E, del Barrio A, Barroso T, Garcia Ruiz PJ. Visual processing disorders in patients with Huntington's disease and asymptomatic carriers. J Neurol 1996; 243: 286-92.
37. Grafman J, Jonas B, Salazar A. Wisconsin Card Sorting Test performance based on location and size of neuroanatomical lesion in Vietnam veterans with penetrating head injury. Percept Mot Skills 1990; 71: 1120-2.
38. Grafton ST, Mazziotta JC, Pahl JJ, St. George-Hyslop P, Haines JL, Gusella J, et al. Serial changes of cerebral glucose metabolism and audate size in persons at risk for Huntington's disease. Arch Neurol 1992; 49: 1161-7.
39. Gray JM, Young AW, Barker WA, Curtis A, Gibson D. Impaired recognition of disgust in Huntington's disease gene carriers. Brain 1997; 120: 2029-38.
40. Gusella JF, Wexler NS, Conneally PM, Naylor SL, Anderson MA, Tanzi RE, et al. A polymorphic DNA marker genetically linked to Huntington's disease. Nature 1983; 306: 234-8.
41. Hedreen JC, Folstein SE. Early loss of neostriatal striosome neurons in Huntington's disease. J Neuropathol Exp Neurol 1995; 54:105-20.
42. Hodges JR, Salmon DP, Butters N. Differential impairment of semantic and episodic memory in Alzheimer's and Huntington's diseases: a controlled prospective study. J Neurol Neurosurg Psychiatry 1990; 53: 1089-95.
43. Hodges JR, Salmon DP, Butters N. Semantic memory impairment in Alzheimer's disease: failure of access or degraded knowledge? Neuropsychologia 1992; 30: 301-14.
44. Houk JC, Wise SP. Distributed modular architectures linking basal ganglia, cerebellum, and cerebral cortex: their role in planning and controlling action. [Review]. Cereb Cortex 1995; 5: 95-110.
45. Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes [see comments]. Cell 1993; 72: 971-83. Comment in: Cell 1993; 72: 817-8.
46. Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes [see comments]. Cell 1993; 72: 971-83. Comment in: Cell 1993; 72: 817-8.
47. Huntington Study Group. Unified Huntington's Disease Rating Scale: reliability and consistency. Mov Disord 1996; 11: 136-42.
48. International Huntington Association (IHA) and the World Federation of Neurology (WFN) Research Group on Huntington's Chorea. Guidelines for the molecular genetics predictive test in Huntington's disease. Neurology 1994; 44: 1533-6.
49. Jason GW, Pajurkova EM, Suchowersky O, Hewitt J, Hilbert C, Reed J, et al. Presymptomatic neuropsychological impairment in Huntington's disease. Arch Neurol 1988; 45: 769-73.
50. Josiassen RC, Curry LM, Mancall EL. Development of neuropsychological deficits in Huntington's disease. Arch Neurol 1983; 40: 791-6.
51. Kieburtz K, Feigin A, McDermott M, Como P, Abwender D, Zimmerman C, et al. A controlled trial of remacemide hydrochloride in Huntington's disease. Mov Disord 1996; 11: 273-7.
52. Lange KW, Sahakian BJ, Quinn NP, Marsden CD, Robbins TW. Comparison of executive and visuospatial memory function in Huntington's disease and dementia of Alzheimer type matched for degree of dementia. J Neurol Neurosurg Psychiatry 1995; 58: 598-606.
53. Lawrence AD. Executive functions and memory in Huntington's disease [PhD thesis]. Cambridge: Department of Experimental Psychology, University of Cambridge; 1997.
54. Lawrence AD, Sahakian BJ. The neuropsychology of fronto-striatal dementias. In: Woods RT, editor. Handbook of the clinical psychology of ageing. Chichester (UK): John Wiley; 1996. p. 243-65.
55. Lawrence AD, Sahakian BJ, Hodges JR, Rosser AE, Lange KW, Robbins TW. Executive and mnemonic functions in early Huntington's disease. Brain 1996; 119: 1633-45.
56. Martin A, Wiggs CL, Lalonde F, Mack L. Word retrieval to letter and semantic cues: a double dissociation in normal subjects using interference tasks. Neuropsychologia 1994; 32: 1487-94.
57. Middleton FA, Strick PL. The temporal lobe is a target of output from the basal ganglia. Proc Natl Acad Sci USA 1996; 93: 8683-7.
58. Milner B. Interhemispheric differences in the localization of psychological processes in man. [Review]. Brit Med Bull 1971; 27: 272-7.
59. Mink JW. The basal ganglia: focused selection and inhibition of competing motor programs. [Review]. Prog Neurobiol 1996; 50: 381-425.
60. Myers RH, Vonsattel JP, Paskevich PA, Kiely DK, Stevens TJ, Cupples LA, et al. Decreased neuronal and increased oligodendroglial densities in Huntington's disease caudate nucleus. J Neuropathol Exp Neurol 1991; 50: 729-42.
61. Nelson HE. National Adult Reading Test (NART) Manual. Windsor (UK): NFER Nelson; 1982.
62. Olton DS, Becker JT, Handelmann GE. Hippocampus, space, and memory. Behav Brain Sci 1979; 2: 313-65.
63. Oscar-Berman M, Zola-Morgan SM. Comparative neuropsychology and Korsakoff's syndrome. I. - Spatial and visual reversal learning. Neuropsychologia 1980a; 18: 499-512.
64. Oscar-Berman M, Zola-Morgan SM. Comparative neuropsychology and Korsakoff's syndrome. II. - Two-choice visual discrimination learning. Neuropsychologia 1980b; 18: 513-25.
65. Oscar-Berman M, Zola-Morgan SM, Oberg RG, Bonner RT. Comparative neuropsychology and Korsakoff's syndrome. III. Delayed response, delayed alternation and DRL performance. Neuropsychologia 1982; 20: 187-202.
66. Owen AM, Downes JJ, Sahakian BJ, Polkey CE, Robbins TW. Planning and spatial working memory following frontal lobe lesions in man. Neuropsychologia 1990; 28: 1021-34.
67. Owen AM, Roberts AC, Polkey CE, Sahakian BJ, Robbins TW. Extra-dimensional versus intra-dimensional set shifting performance following frontal lobe excisions, temporal lobe excisions or amygdalo-hippocampectomy in man. Neuropsychologia 1991; 29: 993-1006.
68. Owen AM, Roberts AC, Hodges JR, Summers BA, Polkey CE, Robbins TW. Contrasting mechanisms of impaired attentional setshifting in patients with frontal lobe damage or Parkinson's disease. Brain 1993; 116: 1159-75.
69. Owen AM, Sahakian BJ, Hodges JR, Summers BA, Polkey CE, Robbins TW. Dopamine-dependent frontostriatal planning deficits in early Parkinson's disease. Neuropsychology 1995a; 9: 126-40.
70. Owen AM, Sahakian BJ, Semple J, Polkey CE, Robbins TW. Visuo-spatial short-term recognition memory and learning after temporal lobe excisions, frontal lobe excisions or amygdalohippocampectomy in man. Neuropsychologia 1995b; 33: 1-24.
71. Robbins TW. Dissociating executive functions of the prefrontal cortex. [Review]. Philos Trans R Soc Lond B Biol Sci 1996; 351; 1463-71.
72. Robbins TW, Brown VJ. The role of the striatum in the mental chronometry of action: a theoretical review. Rev Neurosci 1990; 2: 181-213.
73. Roberts P, Le Dorze G. Semantic verbal fluency in aphasia: a quantitative and qualitative study in test-retest conditions. Aphiosology 1994; 8: 569-82.
74. Roberts AC, Robbins TW, Everitt BJ. The effects of intradimensional and extradimensional shifts on visual discrimination learning in humans and non-human primates. Q J Exp Psychol 1988; 40B: 321-41.
75. Rosenberg NK, Sorensen SA, Christensen AL. Neuropsychological characteristics of Huntington's disease carriers: a double blind study. J Med Genet 1995; 32: 600-4.
76. Rosser A, Hodges JR. Initial letter and semantic category fluency in Alzheimer's disease, Huntington's disease, and progressive supranuclear palsy [see comments]. J Neurol Neurosurg Psychiatry 1994; 57: 1389-94. Comment in: J Neurol Neurosurg Psychiatry 1995; 58: 520-1.
77. Rosser A, Hodges JR. Initial letter and semantic category fluency in Alzheimer's disease, Huntington's disease, and progressive supranuclear palsy [see comments]. J Neurol Neurosurg Psychiatry 1994; 57: 1389-94. Comment in: J Neurol Neurosurg Psychiatry 1995; 58: 520-1.
78. Rosvold HE. The prefrontal cortex and caudate nucleus: a system for effecting correction in response mechanisms. In: Rupp C, editor. Mind as a tissue. New York: Harper & Row; 1968. p. 21-38.
79. Rothlind JC, Brandt J, Zee D, Codori AM, Folstein S. Unimpaired verbal memory and oculomotor control in asymptomatic adults with the genetic marker for Huntington's disease [published erratum appears in Arch Neurol 1994; 51: 268]. Arch Neurol 1993a; 50: 799-802.
80. Rubinsztein DC, Barton DE, Davison BCC, Ferguson-Smith MA. Analysis of the huntingtin gene reveals a trinucleotide-length polymorphism in the region of the gene that contains two CCG-rich stretches and a correlation between decreased age of onset of Huntington's disease and CAG repeat number. Hum Mol Genet 1993; 2: 1713-5.
81. Rubinsztein DC, Leggo J, Coles R, Almquist E, Biancalana V, Cassiman JJ, et al. Phenotypic characterisation of individuals with 30-40 CAG repeats in the Huntington's disease (HD) gene reveals HD cases with 36 repeats and apparently normal elderly individuals with 36-39 repeats. Am J Hum Genet 1996; 59: 16-22.
82. Rubinsztein DC, Leggo J, Chiano M, Dodge A, Norbury G, Rosser E, et al. Genotypes at the GluR6 kainate receptor locus are associated with variation in the age of onset of Huntington disease. Proc Natl Acad Sci USA 1997; 94: 3872-6.
83. Sahakian BJ, Morris RG, Evenden JL, Heald A, Levy R, Philpot M, et al. A comparative study of visuospatial memory and learning in Alzheimer-type dementia and Parkinson's disease. Brain 1988; 111: 695-718.
84. Siemers E, Foroud T, Bill DJ, Sorbel J, Norton JA Jr, Hodes ME, et al. Motor changes in presymptomatic Huntington disease gene carriers. Arch Neurol 1996; 53: 487-92.
85. Sprengelmeyer R, Lange H, Homberg V. The pattern of attentional deficits in Huntington's disease. Brain 1995; 118: 145-52.
86. Strauss ME, Brandt J. Are there neuropsychologic manifestations of the gene for Huntington's disease in asymptomatic, at-risk individuals? Arch Neurol 1990; 47: 905-8.
87. Swerdlow NR, Paulsen J, Braff DL, Butters N, Geyer MA, Swenson MR. Impaired prepulse inhibition of acoustic and tactile startle response in patients with Huntington's disease. J Neurol Neurosurg Psychiatry 1995; 58: 192-200.
88. Vonsattel JP, Myers RH, Stevens TJ, Ferrante RJ, Bird ED, Richardson EP Jr. Neuropathological classification of Huntington's disease. J Neuropathol Exp Neurol 1985; 44: 559-77.
89. Wechsler D. Wechsler Adult Intelligence Scale-Revised, New York: Psychological Corporation; 1987.
90. Weeks RA, Piccini P, Harding AE, Brooks DJ. Striatal D1 and D2 dopamine receptor loss in asymptomatic mutation carriers of Huntington's disease. Ann Neurol 1996; 40: 49-54.
91. Wise SP, Murray EA, Gerfen CR. The frontal cortex-basal ganglia system in primates. [Review]. Crit Rev Neurobiol 1996; 10: 317-56.